House Bill 525 revises North Carolina’s Advisory Council on Rare Diseases, known as Taylor’s Law, by moving the council from the UNC School of Medicine to the Department of Health and Human Services. It updates the council’s membership structure, expands and clarifies the categories of required members, and preserves the council’s role in advising the Governor, the Secretary of Health and Human Services, and the General Assembly on rare disease research, diagnosis, treatment, education, and policy.
The bill also directs the council to continue meeting regularly, reporting annually on its activities and recommendations, and consulting with medical schools, hospitals, the Drug Utilization Review Board, and the Medicaid Preferred Drug List Review Panel. In addition, it appropriates recurring General Fund money to DHHS—$250,000 for each of fiscal years 2025-2026 and 2026-2027—to cover the council’s operating expenses.
HB525 would amend Chapter 130A of the North Carolina General Statutes to relocate administrative responsibility for the Advisory Council on Rare Diseases from the University of North Carolina at Chapel Hill to DHHS, while keeping the council’s advisory mission intact. It would also revise statutory membership, terms, appointment authority, quorum, reporting duties, and administrative support provisions, and it would create a recurring state appropriation to fund the council’s operations. The bill affects DHHS, UNC-related administrative responsibilities, and a broad set of stakeholders in rare disease care, including patients, caregivers, clinicians, researchers, insurers, and the life sciences industry.
The available context suggests generally supportive treatment of the bill, as reflected by its introduction by multiple sponsors and its referral through the House committee process without recorded opposition in the provided materials. The bill’s focus on rare disease awareness, coordination, and funding indicates a policy goal that is likely to draw bipartisan or broad public-health support. No committee transcript or vote record was provided, so there is no documented debate or recorded sentiment beyond the bill’s formal advancement.
The main potential points of contention are structural and fiscal rather than ideological. The bill shifts the council’s home from UNC to DHHS, which may raise questions about administrative control, institutional expertise, and how support services will be delivered. The recurring $250,000 annual appropriation could also prompt scrutiny over state spending, especially if lawmakers question whether the council’s expanded membership and duties justify the ongoing cost. Stakeholders most likely to care about these issues include DHHS, UNC, budget writers, patient advocates, insurers, and industry representatives.